King’s College London vs University of Maryland for public health: which is better for undergrad

The biggest practical tradeoff is specialization versus campus breadth. King’s College London gives you a more directly health-focused environment in a city with major hospitals, the NHS, and global health institutions nearby, while the University of Maryland offers a broader American campus experience with easier access to U.S. public health agencies, policy internships, and the standard pre-grad-school path in the U.S. For public health specifically, both are credible choices, but they position you somewhat differently from day one.

King’s stands out for being embedded in London’s medical and health policy ecosystem. Its connection to a major academic health sciences environment and its location near public-sector, nonprofit, and international health organizations can be very valuable if you want a globally oriented lens on population health, health systems, or epidemiology. King’s can feel more academically focused and city-based, which some students love and others find less community-oriented than a traditional U.S. campus.

Maryland’s advantage is how well it plugs into the U.S. public health pipeline. Being near Washington, DC matters a lot for internships, federal agencies, health nonprofits, advocacy organizations, and research opportunities tied to U.S. policy and public health practice. If you may work in the U.S. after college or apply to U.S. MPH, MSPH, or related graduate programs, Maryland often offers the more straightforward network and credential path.

For undergrad public health strength alone, I would lean Maryland for practicality, especially if your future is likely U.S.-based. The degree will be easier for American employers and grad programs to contextualize, and the internship ecosystem around DC is a real asset. I’d lean King’s instead if you are especially drawn to studying in London, want a more internationally framed health education, and can see yourself building your early career in the UK or in global health settings rather than mainly in the U.S.